CING Stock Analysis: Buy, Sell, or Hold?

CING - Cingulate Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$5.74
0.02 (0.35%) ▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026

Get Alerted When CING Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: CING shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.

In-depth Analysis How we analyze

Valuation Analysis: CING is currently trading at $5.74, which is considered extended relative to its 30-day fair value range of $4.35 to $5.58.

Technical Outlook: Technically, CING is in a uptrend. Immediate support is located at $4.80, while resistance sits at $6.74.

Market Sentiment: CING has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $26.48 (+362.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position EXTENDED
Fair Price Range $4.35 - $5.58
Company Quality Score 56/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 63.2%

All Signals

  • BEARISH: Price extended above range
  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 362.9% below Wall St target ($26.48)

Fair Price Analysis

30-Day Fair Range $4.35 - $5.58
Current vs Fair Value EXTENDED

Support & Resistance Levels

Support Level $4.80
Resistance Level $6.74
Current Trend Uptrend

Fundamental Context

Forward P/E (Next Year Est.) -4.06
Wall Street Target $26.48 (+362.9%)
Last updated: January 31, 2026 3:46 AM ET
Data refreshes hourly during market hours. Next update: 4:45 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ONC
BeiGene, Ltd.
STRONG BUY
24 analysts
$404 63 BUY
RARE
Ultragenyx
STRONG BUY
20 analysts
$64 55 HOLD
RCKT
Rocket Pharmaceuticals I…
STRONG BUY
18 analysts
$8 53 HOLD
INCY
Incyte Corporation
HOLD
27 analysts
$102 62 BUY
CRNX
Crinetics Pharmaceutical…
STRONG BUY
17 analysts
$85 55 HOLD

Advanced CING Option Strategies

Professional options setups generated by AI based on today's CING price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for CING

CING Technical Chart CING Price Prediction CING Investment Advisor CING Fair Price Analyzer CING Options Advisor CING Options Chain CING Options Analysis CING Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals